Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, will be attending a number of upcoming investment and scientific conferences with members of the senior leadership team presenting as follows:
Chardan’s 6th Annual Genetic Medicines Conference
3-4 October, New York City, US
Richard Francis, Chief Executive Officer
3 October, 1PM EST / 6PM BST: Presentation: “Purespring Introduction“
2nd Annual Rare & Genetic Kidney Disease Drug Development
4-6 October, Boston, US
Professor Moin Saleem, Co-founder and Chief Scientific Advisor
4 October, 8AM EST / 1PM BST: Pre-Conference Workshop A: “Shifting the Testing Paradigm: executing more frequent genetic testing to elucidate genomic variation & better characterize genetic disease”
Consilium Strategic Communications 10th Annual Healthcare Conference
14 November, London, UK
Richard Francis, Chief Executive Officer
05PM BST: Panel: “Bursting the Bubbles: Are hot therapeutic areas of investor focus a help or a hindrance to innovation in healthcare?”
If you would like to meet with any of the Purespring team during these events or at any other time, please contact r.muccio@purespringtx.com
